Natixis’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.6K | Buy |
+485
| New | +$50.6K | ﹤0.01% | 857 |
|
|
2025
Q1 | – | Sell |
-748
| Closed | -$63.3K | – | 959 |
|
|
2024
Q4 | $63.3K | Sell |
748
-142
| -16% | -$12K | ﹤0.01% | 855 |
|
|
2024
Q3 | $80K | Sell |
890
-32,762
| -97% | -$2.94M | ﹤0.01% | 749 |
|
|
2024
Q2 | $2.71M | Buy |
33,652
+32,417
| +2,625% | +$2.61M | 0.02% | 356 |
|
|
2024
Q1 | $98.6K | Buy |
1,235
+148
| +14% | +$11.8K | ﹤0.01% | 758 |
|
|
2023
Q4 | $86.5K | Sell |
1,087
-57
| -5% | -$4.54K | ﹤0.01% | 766 |
|
|
2023
Q3 | $80K | Buy |
+1,144
| New | +$80K | ﹤0.01% | 785 |
|